Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Other Non Operating Income: 2011-2024

Historic Other Non Operating Income for Ptc Therapeutics (PTCT) over the last 14 years, with Dec 2024 value amounting to $6.5 million.

  • Ptc Therapeutics' Other Non Operating Income rose 447.33% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 102.53%. This contributed to the annual value of $6.5 million for FY2024, which is 104.76% up from last year.
  • Ptc Therapeutics' Other Non Operating Income amounted to $6.5 million in FY2024, which was up 104.76% from -$137.6 million recorded in FY2023.
  • Ptc Therapeutics' 5-year Other Non Operating Income high stood at $85.2 million for FY2020, and its period low was -$137.6 million during FY2023.
  • Moreover, its 3-year median value for Other Non Operating Income was -$49.2 million (2022), whereas its average is -$60.1 million.
  • Per our database at Business Quant, Ptc Therapeutics' Other Non Operating Income skyrocketed by 520.77% in 2020 and then plummeted by 179.55% in 2023.
  • Ptc Therapeutics' Other Non Operating Income (Yearly) stood at $85.2 million in 2020, then plummeted by 167.94% to -$57.9 million in 2021, then grew by 14.98% to -$49.2 million in 2022, then slumped by 179.55% to -$137.6 million in 2023, then spiked by 104.76% to $6.5 million in 2024.